In the next decade, analysts project that total cannabis industry sales could reach as high as $130 billion. Despite this burgeoning market, public cannabis companies often lack access to institutional capital and large bank financing. Instead, they rely on private placements and venture capital funds.
In 2018, Viridian Capital Advisors estimates that $13.8 billion was raised by cannabis firms, marking a four-fold increase over the year prior. Although the funding exists, securing these deals requires the right contacts and networking opportunities.
MjMicro delivers the next level of investment capital that publicly traded companies need. At MjMicro, presenting companies connect with a vetted roster of high net worth, ultra-high net worth investors and venture capitalists specifically looking to capitalize on publicly traded cannabis companies.
Present and meet with investors 1:1 to access billions of capital through direct investments, and increase open market buying.
Presenting companies are expected to provide proof of concept for their offerings, as well as insight into current and potential revenue streams, audited financials and corporate valuations that are justified by public markets. Qualified companies are encouraged to request an invitation to present.